Semaglutide for Muscle Growth: What the Evidence Shows
What human and animal studies show about Semaglutide for muscle growth, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for muscle growth (PubMed search, 2 Oct 2026)
- Human studies
- None found
- with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
- Animal studies
- None found
- with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
- Studies we summarised
- 1
- with an outcome for muscle growth
Evidence for muscle growth
Each row is an outcome related to muscle growth from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Lean mass | Lean mass losses ranged from almost 0% to 40% of total weight reduction in some studies. | Systematic reviewn = 1541 | Expert opinion on pharmacotherapy 2024, PMID 38629387 |
Semaglutide and muscle growth are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Muscle: the evidence is about losing less, not gaining more
MedlinePlus describes strength training as exercise with weights, resistance bands or your own body weight to build stronger muscles.[2]
No cached trial tested semaglutide for building muscle; the studies ask how much lean mass is lost alongside fat. A systematic review of six trials and observational studies found weight loss came mainly from fat, but lean-mass losses ranged from almost 0% to 40% of total weight reduction.[1]
The Wegovy label itself states that semaglutide lowers body weight with greater fat mass loss than lean mass loss.[3]
How much lean mass goes
A meta-analysis of GLP-1 drugs found lean mass loss made up about 25% of total weight loss, while lean mass as a percentage of body composition was unchanged.[4]
In the same analysis, semaglutide 2.4 mg and tirzepatide 15 mg were the most effective for weight and fat loss but among the least effective at preserving lean mass.[4]
A review of muscle-sparing strategies warns that muscle loss on these drugs may make weight harder to keep off and can lead to sarcopenia, and says the focus should be on cutting fat while minimising muscle loss.[5]
Muscle-targeting add-ons under study
A phase 2 trial combined semaglutide with bimagrumab, an investigational antibody meant to promote muscle growth; the combination lost more weight than semaglutide alone, with average falls of 17.8 kg versus 14.2 kg at 48 weeks.[6]
Reported side effects for bimagrumab included muscle spasms, diarrhoea and acne, and semaglutide's included nausea, diarrhoea, constipation and fatigue.[6]
Other peptides people research for muscle growth
All peptides for muscle growth, comparedCommon questions
Does Semaglutide help with muscle growth?
None of the studies we summarised for Semaglutide (PubMed search, 2 Oct 2026) measured an outcome for muscle growth. Treat claims that it helps with muscle growth as unproven.
Is Semaglutide approved for muscle growth?
Semaglutide is FDA approved (Ozempic, Wegovy, Rybelsus). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for muscle growth?
There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.
Does semaglutide build muscle?
No: the label describes weight lost with greater fat than lean mass loss, not muscle gain.[3]
Will I lose muscle on semaglutide?
Some lean mass is lost with weight loss; the pooled estimate is about 25% of total weight lost.[4]
Is semaglutide used for bodybuilding or cutting?
We found no controlled study of semaglutide in bodybuilders or athletes; the lean-mass data come from people with obesity or diabetes.[4]
More on Semaglutide
Sources
- 1A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.Expert opinion on pharmacotherapy · 2024PMID 38629387Accessed 2 Oct 2026
- 2Official web pageOfficial web page · web page
- 3WEGOVY prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 4Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.Metabolism: clinical and experimental · 2025PMID 39719170Accessed 2 Oct 2026
- 5Saving muscle while losing weight: A vital strategy for sustainable results while on glucagon-like peptide-1 related drugs.World journal of diabetes · 2025PMID 40980310Accessed 2 Oct 2026
- 6Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.Nature medicine · 2026PMID 41772149Accessed 2 Oct 2026
Found an error? Report a correction.